Edgewise Therapeutics, Inc.
EWTX
Rankning i aktier
#3863
Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing... Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically defined muscle conditions. Established in 2017, the company is headquartered in Boulder, Colorado.
Aktiekurs
$39.78
Marknadsvärde
$4.28B
Förändring (1 dag)
4.91%
Förändring (1 år)
158.49%
Land
US
Handel Edgewise Therapeutics, Inc. (EWTX)
Kategori
Healthcare
Historik för aktiesplit för Edgewise Therapeutics, Inc. (EWTX)
Aktien Edgewise Therapeutics, Inc. (symbol: EWTX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 20, 2026.
En EWTX-aktie köpt före Oct 20, 2026 motsvarar nu 0 EWTX-aktier.
Den senaste spliten skedde den Oct 20, 2026.
En EWTX-aktie köpt före Oct 20, 2026 motsvarar nu 0 EWTX-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
